164 related articles for article (PubMed ID: 1489188)
1. Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.
Araujo FG; Prokocimer P; Lin T; Remington JS
Antimicrob Agents Chemother; 1992 Nov; 36(11):2454-7. PubMed ID: 1489188
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
Romand S; Pudney M; Derouin F
Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
Alder J; Hutch T; Meulbroek JA; Clement JC
J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1141-8. PubMed ID: 7932081
[TBL] [Abstract][Full Text] [Related]
4. Rifabutin is active in murine models of toxoplasmosis.
Araujo FG; Slifer T; Remington JS
Antimicrob Agents Chemother; 1994 Mar; 38(3):570-5. PubMed ID: 8203856
[TBL] [Abstract][Full Text] [Related]
5. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
Araujo FG; Lin T; Remington JS
J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
[TBL] [Abstract][Full Text] [Related]
7. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
Martins-Duarte ÉS; de Souza W; Vommaro RC
Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
[TBL] [Abstract][Full Text] [Related]
8. Activity of minocycline against Toxoplasma gondii infection in mice.
Chang HR; Comte R; Piguet PF; Pechère JC
J Antimicrob Chemother; 1991 May; 27(5):639-45. PubMed ID: 1885421
[TBL] [Abstract][Full Text] [Related]
9. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
Romand S; Bryskier A; Moutot M; Derouin F
J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
[TBL] [Abstract][Full Text] [Related]
10. Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.
Khan AA; Lambert LH; Remington JS; Araujo FG
Antimicrob Agents Chemother; 1999 Apr; 43(4):758-62. PubMed ID: 10103177
[TBL] [Abstract][Full Text] [Related]
11. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
[TBL] [Abstract][Full Text] [Related]
12. Nonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondii.
Araujo FG; Slifer T
Antimicrob Agents Chemother; 1995 Dec; 39(12):2696-701. PubMed ID: 8593005
[TBL] [Abstract][Full Text] [Related]
13. Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii.
Chang HR; Arsenijevic D; Comte R; Polak A; Then RL; Pechère JC
Antimicrob Agents Chemother; 1994 Aug; 38(8):1803-7. PubMed ID: 7986011
[TBL] [Abstract][Full Text] [Related]
14. Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis.
Khan AA; Slifer T; Araujo FG; Polzer RJ; Remington JS
Antimicrob Agents Chemother; 1997 May; 41(5):893-7. PubMed ID: 9145840
[TBL] [Abstract][Full Text] [Related]
15. Minocycline in the chemotherapy of murine toxoplasmosis.
Tabbara KF; Sakuragi S; O'Connor GR
Parasitology; 1982 Apr; 84(Pt 2):297-302. PubMed ID: 7070843
[TBL] [Abstract][Full Text] [Related]
16. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
Derouin F; Almadany R; Chau F; Rouveix B; Pocidalo JJ
Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642
[TBL] [Abstract][Full Text] [Related]
17. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii.
Kovacs JA; Allegra CJ; Chabner BA; Swan JC; Drake J; Lunde M; Parrillo JE; Masur H
J Infect Dis; 1987 May; 155(5):1027-32. PubMed ID: 2951446
[TBL] [Abstract][Full Text] [Related]
18. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
[TBL] [Abstract][Full Text] [Related]
19. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.
Araujo FG; Huskinson J; Remington JS
Antimicrob Agents Chemother; 1991 Feb; 35(2):293-9. PubMed ID: 2024964
[TBL] [Abstract][Full Text] [Related]
20. In-vitro and in-vivo activity of rifabutin against Toxoplasma gondii.
Olliaro P; Gorini G; Jabes D; Regazzetti A; Rossi R; Marchetti A; Tinelli C; Della Bruna C
J Antimicrob Chemother; 1994 Nov; 34(5):649-57. PubMed ID: 7706160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
